Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Busulfan

An alkylating agent described in 1953 by Alexander Haddow and Geoffrey Timmis in London, long used for chronic myeloid leukaemia and now also to prepare patients for stem cell transplantation. This family brings together the active ingredient, labelled standards and other impurities.

Did you know?Its structure is surprisingly simple: a chain of four carbon atoms with a methanesulphonate group at each end, able to link the two strands of DNA together.

BusulfanGo to the active ingredient →
BusulfanActive ingredientBusulfanCat. No. P-B146-001CAS 55-98-1
Busulfan-d8Isotopically labelledBusulfan-d8Cat. No. P-B146-002CAS 116653-28-2

EDQM standards 1

The official European Pharmacopoeia standards for this family.

Reference substanceBusulfan CRSEDQM code B1170000Family Busulfan

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.